A Comprehensive Review on Biosimilars: Present & Future

Simple item page
dc.contributor.authorGarai, Pen_US
dc.contributor.authorChakraborty, Aen_US
dc.contributor.authorBanerjee, Men_US
dc.contributor.authorMukherjee, P.en_US
dc.date.accessioned2025-05-12T10:23:17Z
dc.date.available2025-05-12T10:23:17Z
dc.date.issued2024-12
dc.description.abstractFor providing treatment about most complex disease like cancer, hormone inadequacy, kidney problems, life-threatening and many types of rare illnesses biologics are conducting a major role of the biopharmaceutical market. But there are many problems faces that’s are a highly complex process, patent expires, cost effective etc. for those type of reason and more patient demand a similar drug is making which is as similar as biologics drug, simple making process, and less costly. A biologic is a medicine that is biosimilar medical product which is subsequently adaptation of the biologic product or almost an identical substitute of the original product which is manufactured by other brand of company. Although biosimilar drug has FDA approved for manufacturing but they also have to require a different approval for those drug marketing, since they are the reason why they are not a generic form of biologics. Biosimilar drug are not exact copy the originator drug, they are similarly designed the innovator drug. This paper mainly highlighted to the current scenario of biosimilar drug in biopharmaceutical field also the future result of this similar biologic drug in biopharmaceutical field. Biosimilars are hardly offer to promising that it was a beneficial and less cost-effective site for patient and doctors also.en_US
dc.identifier.affiliationsSchool of Pharmacy, Seacom Skills University, Bolpur, West Bengal -731236, Indiaen_US
dc.identifier.affiliationsSchool of Pharmacy, Seacom Skills University, Bolpur, West Bengal -731236, Indiaen_US
dc.identifier.affiliationsSchool of Pharmacy, Seacom Skills University, Bolpur, West Bengal -731236, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmaceutics, M.R. College of Pharmaceutical Sciences and Research, Bira, Balisha, North 24 Pgs, West Bengal-743702 India.en_US
dc.identifier.citationGarai P, Chakraborty A, Banerjee M, Mukherjee P.. A Comprehensive Review on Biosimilars: Present & Future . Journal of Pharmaceutical Research International. 2024 Dec; 36(12): 198-205en_US
dc.identifier.issn2456-9119
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/247684
dc.languageenen_US
dc.publisherMs. M. B. Mondalen_US
dc.relation.issuenumber12en_US
dc.relation.volume36en_US
dc.source.urihttps://doi.org/10.9734/jpri/2024/v36i127639en_US
dc.subjectBiopharmaceutical marketen_US
dc.subjectbiologicsen_US
dc.subjectbiosimilarsen_US
dc.subjectidentical substituteen_US
dc.subjectinnovator drugen_US
dc.titleA Comprehensive Review on Biosimilars: Present & Futureen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
jpri2024v36n12p198.pdf
Size:
375.86 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Pharmaceutical Research International